Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Repasky

Showing results (281-290 of 355) with videos related to

Pageof 36
Sort By:
Melanoma Research|March 7, 2022
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patientsMichael M Wach, John R Subjeck, Xiang-Yang Wang, et al.
International Journal of Qualitative Methods|May 1, 2026
Contributions of Qualitative Methods to Real-Time Implementation Strategy Design: A Case Study Linking Justice Involved Individuals at Risk for HIV to Pre-exposure ProphylaxisRobin T Higashi, Timothy P Hogan, Emily C Repasky, et al.
Vaccines|November 26, 2025
A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune RemodelingXueqian Cheng, Zheng Liu, Jinyang Cai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2015
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor modelBonnie L Hylander, Arindam Sen, Sarah H Beachy, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2015
A role for the thermal environment in defining co-stimulation requirements for CD4(+) T cell activationEvan R Zynda, Melissa J Grimm, Min Yuan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.
Nature Communications|March 11, 2015
Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activationJason W-L Eng, Chelsey B Reed, Kathleen M Kokolus, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 17, 2005
VSGP/F-spondin: a new ovarian cancer markerRuth A Pyle-Chenault, John A Stolk, David A Molesh, et al.
Oncogene|April 12, 2002
Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarraysYuqiu Jiang, Susan L Harlocker, David A Molesh, et al.
Nature|February 18, 2015
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationTea Pemovska, Eric Johnson, Mika Kontro, et al.
Pageof 36

Showing results (281-290 of 355) with videos related to

Sort By:
Pageof 36
Melanoma Research|March 7, 2022
Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patientsMichael M Wach, John R Subjeck, Xiang-Yang Wang, et al.
International Journal of Qualitative Methods|May 1, 2026
Contributions of Qualitative Methods to Real-Time Implementation Strategy Design: A Case Study Linking Justice Involved Individuals at Risk for HIV to Pre-exposure ProphylaxisRobin T Higashi, Timothy P Hogan, Emily C Repasky, et al.
Vaccines|November 26, 2025
A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune RemodelingXueqian Cheng, Zheng Liu, Jinyang Cai, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 7, 2015
Tumor priming by Apo2L/TRAIL reduces interstitial fluid pressure and enhances efficacy of liposomal gemcitabine in a patient derived xenograft tumor modelBonnie L Hylander, Arindam Sen, Sarah H Beachy, et al.
Cell Cycle (Georgetown, Tex.)|July 2, 2015
A role for the thermal environment in defining co-stimulation requirements for CD4(+) T cell activationEvan R Zynda, Melissa J Grimm, Min Yuan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010Gregory B Lesinski, William E Carson, Elizabeth A Repasky, et al.
Nature Communications|March 11, 2015
Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activationJason W-L Eng, Chelsey B Reed, Kathleen M Kokolus, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 17, 2005
VSGP/F-spondin: a new ovarian cancer markerRuth A Pyle-Chenault, John A Stolk, David A Molesh, et al.
Oncogene|April 12, 2002
Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarraysYuqiu Jiang, Susan L Harlocker, David A Molesh, et al.
Nature|February 18, 2015
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformationTea Pemovska, Eric Johnson, Mika Kontro, et al.
Pageof 36